Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
ChromaTan Inc. is not a typical SaaS or enterprise software vendor, but a technology platform company focused on the purification stage of biomanufacturing. Its website highlights Kascade™ BioRMB™, positioned as a continuous, column-free chromatography purification platform designed to improve bioprocess productivity, product quality, and recovery. Its target applications include gene therapy products, fusion proteins, DNA, mRNA, and other biomolecules that are sensitive to shear, pressure, and contact time.
Based on the collected content, the core of Kascade™ BioRMB™ lies in true moving bed technology and multistage countercurrent extraction, supporting true steady-state, low-pressure operation. The platform claims to enable a 10x reduction in resin volume, up to 70% OpEx savings, and rapid resin cycling at 3-5 cycles/hour. Its single-use, fully enclosed, easy-to-install flow path can reduce the need for column packing, cleaning, and resin storage, while simplifying validation processes. The product page also states that Kascade™ BioRMB™ supports flow rates of 2-25 mL/min and resin volumes of 7.5-50 mL, and can be used for online DOE, preclinical purification, and the production of GMP-grade clinical materials using sterile single-use flow paths.
The website does not disclose pricing, packages, subscriptions, licensing, or maintenance fees, nor is there any free trial information. The pages repeatedly direct users to Contact Us for partnership, investment, and product details, suggesting a high-ticket, project-based procurement model or customized equipment/process platform delivery rather than a standard self-service software model.
Its strengths lie in its highly vertical technical positioning, with differentiation built around continuous purification, low-pressure and low-shear operation, and recovery of sensitive molecules. It is also endorsed by winning the 2024 Bioprocessing Summit People’s Choice Awards. The single-use flow path and column-free design may also help reduce the operational complexity of traditional chromatography. Limitations include the lack of detailed customer case studies, compliance certifications, delivery models, and after-sales support information on the website. CCTC PiPe and CCTC Max are still marked as Coming Soon, with descriptions that appear to be placeholder text. As an enterprise software evaluation target, information about APIs, permissions, integrations, data security, cloud/self-hosted deployment, and similar areas is not disclosed.
It is better suited for biopharmaceutical companies with needs in bioprocess development, continuous manufacturing, and GMP clinical material production, rather than enterprise users looking for general-purpose SaaS. Access from China cannot be determined from the available content and is marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on chromatan.com official site.
chromatan.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach chromatan.com directly.